Your browser doesn't support javascript.
loading
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.
Whyte, Claire S; Morrow, Gael B; Mitchell, Joanne L; Chowdary, Pratima; Mutch, Nicola J.
Affiliation
  • Whyte CS; Aberdeen Cardiovascular & Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Aberdeen, UK.
  • Morrow GB; Aberdeen Cardiovascular & Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Aberdeen, UK.
  • Mitchell JL; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Chowdary P; Institute of Cardiovascular and Metabolic Sciences, School of Biological Sciences, University of Reading, Reading, UK.
  • Mutch NJ; Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital, London, UK.
J Thromb Haemost ; 18(7): 1548-1555, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32329246
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumonia, Viral / Thrombolytic Therapy / Tissue Plasminogen Activator / Coronavirus Infections / Fibrinolysis / Fibrinolytic Agents / Betacoronavirus Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pneumonia, Viral / Thrombolytic Therapy / Tissue Plasminogen Activator / Coronavirus Infections / Fibrinolysis / Fibrinolytic Agents / Betacoronavirus Type of study: Diagnostic_studies Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: United kingdom